Historical Stock Price
ECYT historical stock prices picture
ECYT (ECYT) has the following price history information. Looking back at ECYT historical stock prices for the last five trading days, on December 17, 2018, ECYT opened at $23.96, traded as high as $23.98 and as low as $23.95, and closed at $23.96. Trading volume was a total of 3.91M shares. On December 18, 2018, ECYT opened at $23.96, traded as high as $23.99 and as low as $23.96, and closed at $23.97. Trading volume was a total of 2.75M shares. On December 19, 2018, ECYT opened at $23.99, traded as high as $24.00 and as low as $23.97, and closed at $24.00. Trading volume was a total of 2.26M shares. On December 20, 2018, ECYT opened at $23.99, traded as high as $24.00 and as low as $23.99, and closed at $23.99. Trading volume was a total of 2.34M shares. On December 21, 2018, ECYT opened at $23.99, traded as high as $23.99 and as low as $23.99, and closed at $23.99. Trading volume was a total of 0 shares.

ECYT Historical Stock Prices By Date:

ECYT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ECYT shares, starting with a $10,000 purchase of ECYT, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 12/21/2018
Start price/share: $23.81
End price/share: $23.99
Dividends collected/share: $0.00
Total return: 0.76%
Average Annual Total Return: 0.16%
Starting investment: $10,000.00
Ending investment: $10,075.89
Years: 4.73
Date Open High Low Close Volume
12/17/2018 $23.96 $23.98 $23.95 $23.96 3.91M
12/18/2018 $23.96 $23.99 $23.96 $23.97 2.75M
12/19/2018 $23.99 $24.00 $23.97 $24.00 2.26M
12/20/2018 $23.99 $24.00 $23.99 $23.99 2.34M
12/21/2018 $23.99 $23.99 $23.99 $23.99 0
Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer. Co. uses drug conjugation technology to create therapeutics and companion imaging agents for personalized targeted therapies. Co.'s agents target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (PSMA) in prostate cancer. Co. has rights to develop and commercialize PSMA-617 agents, including the drug candidate known as 177Lu-PSMA-617, a radioligand therapeutic. Co. is also developing a therapeutic approach that involves the re-targeting of potent immune cells, called chimeric antigen receptor T-cells to fight cancer.
Date Close
12/17/2018$23.96
12/18/2018$23.97
12/19/2018$24.00
12/20/2018$23.99
12/21/2018$23.99
ECYT is categorized under the Healthcare sector; below are some other companies in the same sector:

EDAP Historical Stock Prices
EDGE Historical Stock Prices
EDIT Historical Stock Prices
EGLT Historical Stock Prices
EGRX Historical Stock Prices
EHC Historical Stock Prices
EIGR Historical Stock Prices
EKG Historical Stock Prices
EKO Historical Stock Prices
EKSO Historical Stock Prices

Also explore: ECYT shares outstanding history

Email EnvelopeFree ECYT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ECYT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.